Retrospective studies have shown that high tumor expression of programmed cell death-ligand 1 (PD-L1), known to inhibit T-cell function when bound to the programmed cell death-1 (PD-1) protein, is associated with poor prognosis in patients with mesothelioma [29,30]. Here, PDCD1 is linked to neoplasm.